JO

Journal Of Thoracic Oncology

Journal of Thoracic Oncology is the official journal of the International Association for the Study of Lung Cancer and the primary educational and informational publication for prevention, detection, diagnosis, and treatment of thoracic malignancies. It emphasizes a multidisciplinary approach and includes original research, reviews, and opinion pieces for clinicians and research scientists with an interest in thoracic oncology.

Looking to publish in Journal Of Thoracic Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology, Respiratory System
Impact Factor 20.8
Quartile Q1
Open Access Type Hybrid
ISSN 1556-0864
eISSN 1556-1380
Invitation Only No
Cost Range Hybrid journal with open access content; publication cost not specified

Submission Instructions

Journal Of Thoracic Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Original Articles must include a structured abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Original Articles must contain 4,000 words of text. The manuscript must be organized under the main headings Introduction, Materials and Methods, Results, and Discussion. The manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in writing, a Declaration of Generative AI and AI-assisted technologies in the writing process before the references.
References Original Articles may include up to 50 references. References must be cited in the text as consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Original Articles may include up to 6 tables and/or figures. Each illustration must be submitted as a separate file. Tables must be submitted as editable text rather than images.
Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must be limited to 250 words. Abstract must be structured. Abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Review Articles should be no longer than 4000 words. Manuscript must be organized under the four main headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in writing, a 'Declaration of Generative AI and AI-assisted technologies in the writing process' section before the references.
References Review Articles may include no more than 75 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Review Articles may include up to 6 tables and/or figures. Each illustration must be submitted as a separate file. Review Article figures should preferably be submitted as vector-based .eps, .ai, .ps, .pdf, or .svg files, may be submitted as .pptx, .docx, or .xlsx files, and should not be submitted as .png, .jpeg, .tiff, or .bmp files.
Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Brief Reports must include an abstract. The abstract must be limited to 250 words. The abstract must be structured. The abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Brief Reports must have a maximum length of 1500 words. The manuscript must be organized under the main headings Introduction, Materials and Methods, Results, and Discussion. Brief Reports must include "Brief Report:" in the title and include three to five keywords, and any use of generative AI in writing must be disclosed in a section titled 'Declaration of Generative AI and AI-assisted technologies in the writing process' before the references.
References Brief Reports may include a maximum of 15 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Brief Reports may include up to 3 tables and/or figures. Each illustration must be submitted as a separate file. Tables must be submitted as editable text rather than images.
Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Case Reports must include an abstract. Case Report abstracts may be structured or unstructured. Case Report abstracts must include an introduction on the case's uniqueness and contribution, the patient's main concerns and key clinical findings, the primary diagnoses, interventions, and outcomes, and a conclusion with one or more take-away lessons.
Manuscript Case Reports must be 1000 words or less. Case Reports must include Introduction, Case Presentation, Discussion, and a one-paragraph Conclusion sections, and they must include a timeline as a figure or table. Case Reports must include 2 to 5 keywords including "case report," a disclosure statement of conflict of interest, a short Acknowledgement mentioning funding support if applicable, and a statement of patient's informed consent.
References Case Reports may include no more than 5 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order they appear in the text.
Figures & Tables Case Reports may include up to 3 figures and/or tables. Each illustration must be submitted as a separate file. Case Reports must include a timeline presented as a figure or table.
Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters To The Editor must contain no more than 500 words. Letters To The Editor must be accompanied by a statement of potential sources of conflict of interest.
References Letters To The Editor may include no more than 5 references, including a reference to the article in question. References must be indicated in the text by consecutive superscript arabic numerals and listed in the order in which they appear in the text.
Figures & Tables Figures must be submitted as separate files, and tables must be submitted as editable text rather than images. Figure captions must be supplied separately.
Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Rapid Communications

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Manuscript must not exceed 1,000 words excluding references, figures, and tables. Manuscript must be organized into the four main headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in the writing process, a 'Declaration of Generative AI and AI-assisted technologies in the writing process' section before the References list.
References Rapid Communications may include no more than 5 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Rapid Communications may include no more than 1 table or figure. Each illustration must be submitted as a separate file. Tables must be submitted as editable text and not as images.
Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Recent Publications

Thymic Composition Predicts Radiation Pneumonitis in Locally Advanced NSCLC

Tafadzwa L. Chaunzwa, Gokul Krishnan, Abraham J. Book, David G. Miller, Kwadwo Amoako-Boadu, Biniam Garomsa, Yuzhong J. Meng, Elaine Yang, Jennifer Ma, Alexis Chidi, Daniel R. Gomez, Narek Shaverdian

10.1016/j.jtho.2026.103949
View Publication

Compound EGFR mutations are predominantly PACC (P-loop and alpha-C helix compressing) mutations with increased responsiveness to second- vs third-generation tyrosine kinase inhibitors

Ximeng Liu, Moses Stamboulian, Maxime Borgeaud, Erjia Zhu, Caroline Weipert, Nicole Zhang, Monique B. Nilsson, Kaiwen Wang, Lingzhi Hong, Jinghao Wang, Benjamin B. Morris, Simon Heeke, Jacqulyne P. Robichaux, Courtney Lewis, Leylah Drusbosky, Hong Chen, Yan Yang, Junqin He, Li Cai, Jia Wu, Jianjun Zhang, Addeo Alfredo, John V. Heymach, Xiuning Le

10.1016/j.jtho.2026.103948
View Publication

Corrigendum to ‘Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype’ [Journal of Thoracic Oncology Volume 21 Issue 4 (2026) 103529]

David T. Severson, Samuel Freyaldenhoven, Benjamin Wadowski, Yin P. Hung, Travis Hughes, Beow Y. Yeap, William G. Richards, Sanna Laaksonen, Lucian Chirieac, Matthew B. Couger, Roderick V. Jensen, Ahmed A. Sadek, Ilkka Ilonen, Kimberly Vermilya, Simona Innocenti, Stephanie L. Korle, Julianne S. Barlow, Jamie Anderson, Jason Meyerovitz, Vivian Wang, Mary N. Dao, Alex K. Shalek, Assunta De Rienzo, Raphael Bueno

10.1016/j.jtho.2026.103915
View Publication

Segmentectomy versus lobectomy in non-small-cell lung cancer with pathologically invasive features: a post-hoc supplementary analysis of a multicenter, Phase 3 trial JCOG0802/WJOG4607L

Shinya Katsumata, Atsushi Kamigaichi, Takaki Akamine, Mitsuhiro Isaka, Masashi Wakabayashi, Noriko Mitome, Masaya Yotsukura, Takahiro Mimae, Aritoshi Hattori, Tomohiro Miyoshi, Makoto Endo, Kazuo Nakagawa, Hiroshige Yoshioka, Yasuhiro Tsutani, Tetsuya Isaka, Tomohiro Maniwa, Yoshihisa Shimada, Ryu Nakajima, Kenji Suzuki, Keiju Aokage, Hisashi Saji, Masahiro Tsuboi, Morihito Okada, Hisao Asamura, Yuta Sekino, Kenichi Nakamura, Haruhiko Fukuda, Shun-ichi Watanabe

10.1016/j.jtho.2026.103916
View Publication

Genetic Predisposition to Lung Cancer Is Modulated by Sex, Smoking, and Ancestry

Stephanie Tuminello, Yuki Joyama, Emanuela Taioli

10.1016/j.jtho.2026.103559
View Publication

Frequently asked questions

How long does it take to publish?

4 days from submission to first decision; 5 days from acceptance to online publication

Reformat to Journal Of Thoracic Oncology using Livewrite Premium

What are the publication costs?

Open access options are available; CC BY licenses are available only by request for authors whose funding bodies require it.

Reformat to Journal Of Thoracic Oncology using Livewrite Premium

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers Radiomics and Machine Learning in Medical Imaging Cancer Genomics and Diagnostics Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes RNA modifications and cancer Cancer Diagnosis and Treatment Medical Imaging and Pathology Studies Occupational and environmental lung diseases Neuroendocrine Tumor Research Advances Pleural and Pulmonary Diseases Brain Metastases and Treatment Head and Neck Cancer Studies Multiple and Secondary Primary Cancers Peptidase Inhibition and Analysis Global Cancer Incidence and Screening Medical Imaging Techniques and Applications Metastasis and carcinoma case studies HER2/EGFR in Cancer Research Cancer therapeutics and mechanisms Myasthenia Gravis and Thymoma Esophageal Cancer Research and Treatment

Related Journals

CO
Copd-journal Of Chronic Obstructive Pulmonary Disease Informa
RM
Respiratory Medicine Case Reports Elsevier BV
JO
Journal Of Nursing Regulation Elsevier BV
LH
Lancet Healthy Longevity Elsevier BV
LC
Liver Cancer Karger Publishers
JR
Jhep Reports Elsevier BV